Skip to Content

Valeo Pharma Inc Ordinary Shares VP2

Morningstar Rating
CAD 0.06 +0.05 (566.67%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VP2 is trading at a 885% premium.
Price
€0.06
Fair Value
€9.87
Uncertainty
Extreme
1-Star Price
€3.88
5-Star Price
€9.21
Economic Moat
Qgtfk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VP2 is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 0.01
Day Range
CAD 0.060.06
52-Week Range
CAD 0.011.19
Bid/Ask
CAD 0.00 / CAD 0.00
Market Cap
CAD 5.92 Mil
Volume/Avg
86,000 /

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
125

Valuation

Metric
VP2
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.09
Price/Cash Flow
Price/Earnings
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRKhvjjmsccRzfpg$78.2 Bil
ZTS
Zoetis Inc Class APdxjsrwljGmjcc$78.0 Bil
HLN
Haleon PLC ADRZwhcpmxjKpp$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVsdxpfywhYkf$19.1 Bil
VTRS
Viatris IncBfnwltgpHdm$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGmyfhrnhfBdl$11.8 Bil
CTLT
Catalent IncNtxmwjqWkmwn$9.9 Bil
PRGO
Perrigo Co PLCMkhwnsrKlfg$3.8 Bil
CURLF
Curaleaf Holdings IncPvldvrkGqz$3.5 Bil
PBH
Prestige Consumer Healthcare IncPvhjlwyfLvlvcyl$3.2 Bil

Sponsor Center